Unione Europea -
italiano -
EMA (European Medicines Agency)
lunsumio
roche registration gmbh - mosunetuzumab - linfoma, follicolare - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
bendamustina aurobindo
eugia pharma (malta) limited - bendamustina - bendamustina
Unione Europea -
italiano -
EMA (European Medicines Agency)
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - agenti antineoplastici - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.